Gossamer Bio Statistics Share Statistics Gossamer Bio has 227.38M
shares outstanding. The number of shares has increased by 0.48%
in one year.
Shares Outstanding 227.38M Shares Change (YoY) 0.48% Shares Change (QoQ) 0.04% Owned by Institutions (%) 74.94% Shares Floating 182.73M Failed to Deliver (FTD) Shares 12,780 FTD / Avg. Volume 0.51%
Short Selling Information The latest short interest is 18.12M, so 7.97% of the outstanding
shares have been sold short.
Short Interest 18.12M Short % of Shares Out 7.97% Short % of Float 8.49% Short Ratio (days to cover) 11.65
Valuation Ratios The PE ratio is -3.62 and the forward
PE ratio is -3.76.
Gossamer Bio's PEG ratio is
0.05.
PE Ratio -3.62 Forward PE -3.76 PS Ratio 1.78 Forward PS 8.7 PB Ratio 6.94 P/FCF Ratio -59.01 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Gossamer Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.88,
with a Debt / Equity ratio of 6.88.
Current Ratio 6.88 Quick Ratio 6.88 Debt / Equity 6.88 Debt / EBITDA -5.08 Debt / FCF -58.5 Interest Coverage -5.2
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $796.53K Profits Per Employee $-392.56K Employee Count 144 Asset Turnover 0.36 Inventory Turnover n/a
Taxes Income Tax 893K Effective Tax Rate -1.61%
Stock Price Statistics The stock price has increased by 118.87% in the
last 52 weeks. The beta is 1.96, so Gossamer Bio's
price volatility has been higher than the market average.
Beta 1.96 52-Week Price Change 118.87% 50-Day Moving Average 1.5 200-Day Moving Average 1.12 Relative Strength Index (RSI) 50.43 Average Volume (20 Days) 2,517,420
Income Statement In the last 12 months, Gossamer Bio had revenue of 114.7M
and earned -56.53M
in profits. Earnings per share was -0.25.
Revenue 114.7M Gross Profit 114.7M Operating Income -59.92M Net Income -56.53M EBITDA -39.97M EBIT -44.12M Earnings Per Share (EPS) -0.25
Full Income Statement Balance Sheet The company has 46.07M in cash and 202.88M in
debt, giving a net cash position of -156.81M.
Cash & Cash Equivalents 46.07M Total Debt 202.88M Net Cash -156.81M Retained Earnings -1.27B Total Assets 240.93M Working Capital 182.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.47M
and capital expenditures 0, giving a free cash flow of -3.47M.
Operating Cash Flow -3.47M Capital Expenditures n/a Free Cash Flow -3.47M FCF Per Share -0.02
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -52.24% and -49.28%.
Gross Margin 100% Operating Margin -52.24% Pretax Margin -48.5% Profit Margin -49.28% EBITDA Margin -34.84% EBIT Margin -52.24% FCF Margin -3.02%
